Notice of Meeting for the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC), 11846-11847 [2024-03165]
Download as PDF
<![CDATA[
11846
Federal Register / Vol. 89, No. 32 / Thursday, February 15, 2024 / Notices
It is determined that the Cures
Acceleration Network Review Board, is
in the public interest in connection with
the performance of duties imposed on
the National Institutes of Health by law,
and that these duties can best be
performed through the advice and
counsel of this group.
Inquiries may be directed to Claire
Harris, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or harriscl@mail.nih.gov.
Dated: February 9, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–03110 Filed 2–14–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Charter
Renewal
khammond on DSKJM1Z7X2PROD with NOTICES
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
Section 102–3.65(a), notice is hereby
given that the charter for the National
Center for Advancing Translational
Sciences Advisory Council, was
renewed for an additional two-year
period on February 7, 2024.
It is determined that the National
Center for Advancing Translational
Sciences Advisory Council, is in the
public interest in connection with the
performance of duties imposed on the
National Institutes of Health by law, and
that these duties can best be performed
through the advice and counsel of this
group.
Inquiries may be directed to Claire
Harris, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or harriscl@mail.nih.gov.
Dated: February 9, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–03104 Filed 2–14–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:36 Feb 14, 2024
Jkt 262001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The invention listed below is
owned by an agency of the U.S.
Government and is available for
licensing to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Daniel Lee at 301–761–6327 or
daniel.lee5@nih.gov. Licensing
information may be obtained by
communicating with the Technology
Transfer and Intellectual Property
Office, National Institute of Allergy and
Infectious Diseases, 5601 Fishers Lane,
Rockville, MD 20852; tel. 301–496–
2644. A signed Confidential Disclosure
Agreement will be required to receive
copies of unpublished information
related to the invention.
SUPPLEMENTARY INFORMATION:
Technology description follows:
SUMMARY:
DeePlexing—Extending Imaging
Multiplexity Using Machine Learning
Description of Technology: Spatial
proteomics and transcriptomics are fastemerging fields with the potential to
revolutionize various branches of
biology. In the last five years, various
multiplex immunofluorescence and
immunohistochemistry imaging
methods have been developed to stain
5–60 different protein markers in a
given tissue. Nonetheless, most of these
techniques are iterative and can image
a maximum of 3–8 markers in a single
cycle, resulting in processing time of
several hours to days.
Scientists at National Institute of
Allergy and Infectious Diseases (NIAID)
and National Cancer Institute (NCI) have
developed a new method—
DeePlexing—that uses a deep learning
algorithm to dramatically enhance the
number of markers stained in a single
imaging cycle. This is accomplished
with no changes or upgrades to the
imaging platform itself. In the
DeePlexing method, multiple
antibodies/probes are conjugated to the
same fluorophores and later
deconvolved computationally to retrieve
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
the multichannel signal with high
accuracy. In digital spatial profiling,
DeePlexing enables the user to detect
seven different protein markers in a
single cycle using only three
fluorophores and even quadruple the
number of markers in a single round
without compromising the quality of
RNA and protein in the sample. For
multiplex protein profiling, DeePlexing
can potentially stain for up to 255
different protein markets with eight
fluorophores and deconvolve the signal
for each of the 255 markers
computationally.
This technology is available for
licensing for commercial development
in accordance with 35 U.S.C. 209 and 37
CFR part 404.
Potential Commercial Applications:
• Imaging platforms in spatial
transcriptomics
• Multiplex protein spatial imaging
Competitive Advantages:
• Enhances the number of markers
stained in a single imaging cycle
• Achieves this marker detection
increase without compromising RNA
or protein quality when that is part of
the analytical pipeline
• Reduces the required processing time
for multiplex imaging platforms
• Inexpensive and replicable
Development Stage:
• Prototype
Inventors: Ronald N. Germain
(NIAID), Spencer M. Grant (NIAID),
Nishant Thakur (NIAID), Chen Zhao
(NCI), and Abigail J. Wong-Rolle (NCI).
Intellectual Property: HHS Reference
No. E–202–2021–0; Software Tool.
Licensing Contact: To license this
technology, please contact Daniel Lee at
301–761–6327 or daniel.lee5@nih.gov,
and reference E–202–2021–0.
Dated: February 9, 2024.
Surekha Vathyam,
Deputy Director,Technology Transfer and
Intellectual Property Office,National Institute
of Allergy and Infectious Diseases.
[FR Doc. 2024–03120 Filed 2–14–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Notice of Meeting for the
Interdepartmental Serious Mental
Illness Coordinating Committee
(ISMICC)
Substance Abuse and Mental
Health Services Administration,
Department of Health and Human
Services.
AGENCY:
E:\FR\FM\15FEN1.SGM
15FEN1
Federal Register / Vol. 89, No. 32 / Thursday, February 15, 2024 / Notices
ACTION:
Notice.
The Secretary of Health and
Human Services announces a meeting of
the Interdepartmental Serious Mental
Illness Coordinating Committee
(ISMICC).
The meeting will provide information
on federal efforts related to serious
mental illness (SMI) and serious
emotional disturbance (SED); the
Olmstead Decision: 25 Years of History
in the Making; SMI Advisor: A Modern
Approach to Technical Assistance that
Makes an Impact; and Report Outs from
Focus Area 1—Data and Evaluation;
Focus Area 2—Access and Engagement;
Focus Area 3—Treatment and Recovery;
Focus Area 4—Criminal Justice and
Focus Area 5—Finance.
DATES: March 27, 2024, 9:00 a.m. to 4:00
p.m. (EST)/Open.
ADDRESSES: The meeting is open to the
public and can be accessed virtually
only by accessing: https://
www.zoomgov.com/j/1611468532?pwd=
b0xnU2dTbFJqQXlONkJkUzdjdzhtZz09
or by dialing 646–828–7666, webinar ID:
161 146 8532, passcode: 127885.
Agenda with call-in information will be
posted on the SAMHSA website prior to
the meeting at https://www.samhsa.gov/
about-us/advisory-councils/meetings.
FOR FURTHER INFORMATION CONTACT:
Pamela Foote, ISMICC Designated
Federal Officer, SAMHSA, 5600 Fishers
Lane, Rockville, MD 20857; telephone:
240–276–1279; email: pamela.foote@
samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
I. Background and Authority
The ISMICC was established on
March 15, 2017, in accordance with
section 6031 of the 21st Century Cures
Act, and the Federal Advisory
Committee Act, 5 U.S.C. App., as
amended, to report to the Secretary,
Congress, and any other relevant federal
department or agency on advances in
SMI and SED, research related to the
prevention of, diagnosis of, intervention
in, and treatment and recovery of SMIs,
SEDs, and advances in access to services
and supports for adults with SMI or
children with SED. In addition, the
ISMICC will evaluate the effect federal
programs related to SMI and SED have
on public health, including public
health outcomes such as: (A) rates of
suicide, suicide attempts, incidence and
prevalence of SMIs, SEDs, and
substance use disorders, overdose,
overdose deaths, emergency
hospitalizations, emergency room
boarding, preventable emergency room
visits, interaction with the criminal
justice system, homelessness, and
VerDate Sep<11>2014
18:36 Feb 14, 2024
Jkt 262001
unemployment; (B) increased rates of
employment and enrollment in
educational and vocational programs;
(C) quality of mental and substance use
disorders treatment services; or (D) any
other criteria determined by the
Secretary. Finally, the ISMICC will
make specific recommendations for
actions that agencies can take to better
coordinate the administration of mental
health services for adults with SMI or
children with SED. Not later than one
(1) year after the date of enactment of
the 21st Century Cures Act, and five (5)
years after such date of enactment, the
ISMICC shall submit a report to
Congress and any other relevant federal
department or agency.
II. Membership
This ISMICC consists of federal
members listed below or their
designees, and non-federal public
members.
Federal Membership: Members
include, The Secretary of Health and
Human Services; The Assistant
Secretary for Mental Health and
Substance Use; The Attorney General;
The Secretary of the Department of
Veterans Affairs; The Secretary of the
Department of Defense; The Secretary of
the Department of Housing and Urban
Development; The Secretary of the
Department of Education; The Secretary
of the Department of Labor; The
Administrator of the Centers for
Medicare and Medicaid Services; the
Administrator of the Administration for
Community Living, and The
Commissioner of the Social Security
Administration.
Non-Federal Membership: Members
include, not less than 14 non-federal
public members appointed by the
Secretary, representing psychologists,
psychiatrists, social workers, peer
support specialists, and other providers,
patients, family of patients, law
enforcement, the judiciary, and leading
research, advocacy, or service
organizations.
The ISMICC is required to meet at
least twice per year.
To attend virtually, submit written or
brief oral comments, or request special
accommodation for persons with
disabilities, contact Pamela Foote.
Individuals can also register at https://
snacregister.samhsa.gov/.
The public comment section will be
scheduled at the conclusion of the
meeting. Individuals interested in
submitting a comment, must notify
Pamela Foote on or before March 18,
2024, via email to: Pamela.Foote@
samhsa.hhs.gov.
Up to three minutes will be allotted
for each approved public comment as
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
11847
time permits. Written comments
received in advance of the meeting will
be considered for inclusion in the
official record of the meeting.
Substantive meeting information and
a roster of Committee members is
available at the Committee’s website:
https://www.samhsa.gov/about-us/
advisory-councils/ismicc.
Dated: February 12, 2024.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2024–03165 Filed 2–14–24; 8:45 am]
BILLING CODE 4162–20–P
ADVISORY COUNCIL ON HISTORIC
PRESERVATION
Notice of Adoption of Policy Statement
on Housing and Historic Preservation
Advisory Council on Historic
Preservation.
ACTION: Notice of adoption of policy
statement on housing and historic
preservation.
AGENCY:
The Advisory Council on
Historic Preservation has adopted its
Policy Statement on Housing and
Historic Preservation.
DATES: The policy statement was
adopted and went into effect on
December 22, 2023.
FOR FURTHER INFORMATION CONTACT:
Druscilla Null, (202) 517–1487, dnull@
achp.gov.
SUPPLEMENTARY INFORMATION: The
Advisory Council on Historic
Preservation (ACHP), an independent
Federal agency created by the National
Historic Preservation Act (NHPA),
works to promote the preservation,
enhancement, and sustainable use of
our nation’s diverse historic resources,
and advises the President and the
Congress on national historic
preservation policy.
Under the NHPA, the ACHP’s duties
include advising the President and
Congress on matters relating to historic
preservation; recommending measures
to coordinate activities of Federal, state,
and local agencies and private
institutions and individuals related to
historic preservation; and advising on
the dissemination of information
pertaining to those activities. In keeping
with these mandates, in June 2023 the
ACHP initiated discussions regarding
the role that rehabilitation of historic
buildings can play in alleviating
America’s housing shortage and how the
ACHP might advise and assist Federal
agencies and other stakeholders on the
topic.
SUMMARY:
E:\FR\FM\15FEN1.SGM
15FEN1
]]>Agencies
[Federal Register Volume 89, Number 32 (Thursday, February 15, 2024)]
[Notices]
[Pages 11846-11847]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03165]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Notice of Meeting for the Interdepartmental Serious Mental
Illness Coordinating Committee (ISMICC)
AGENCY: Substance Abuse and Mental Health Services Administration,
Department of Health and Human Services.
[[Page 11847]]
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Secretary of Health and Human Services announces a meeting
of the Interdepartmental Serious Mental Illness Coordinating Committee
(ISMICC).
The meeting will provide information on federal efforts related to
serious mental illness (SMI) and serious emotional disturbance (SED);
the Olmstead Decision: 25 Years of History in the Making; SMI Advisor:
A Modern Approach to Technical Assistance that Makes an Impact; and
Report Outs from Focus Area 1--Data and Evaluation; Focus Area 2--
Access and Engagement; Focus Area 3--Treatment and Recovery; Focus Area
4--Criminal Justice and Focus Area 5--Finance.
DATES: March 27, 2024, 9:00 a.m. to 4:00 p.m. (EST)/Open.
ADDRESSES: The meeting is open to the public and can be accessed
virtually only by accessing: https://www.zoomgov.com/j/1611468532?pwd=b0xnU2dTbFJqQXlONkJkUzdjdzhtZz09 or by dialing 646-828-
7666, webinar ID: 161 146 8532, passcode: 127885. Agenda with call-in
information will be posted on the SAMHSA website prior to the meeting
at https://www.samhsa.gov/about-us/advisory-councils/meetings.
FOR FURTHER INFORMATION CONTACT: Pamela Foote, ISMICC Designated
Federal Officer, SAMHSA, 5600 Fishers Lane, Rockville, MD 20857;
telephone: 240-276-1279; email: [email protected].
SUPPLEMENTARY INFORMATION:
I. Background and Authority
The ISMICC was established on March 15, 2017, in accordance with
section 6031 of the 21st Century Cures Act, and the Federal Advisory
Committee Act, 5 U.S.C. App., as amended, to report to the Secretary,
Congress, and any other relevant federal department or agency on
advances in SMI and SED, research related to the prevention of,
diagnosis of, intervention in, and treatment and recovery of SMIs,
SEDs, and advances in access to services and supports for adults with
SMI or children with SED. In addition, the ISMICC will evaluate the
effect federal programs related to SMI and SED have on public health,
including public health outcomes such as: (A) rates of suicide, suicide
attempts, incidence and prevalence of SMIs, SEDs, and substance use
disorders, overdose, overdose deaths, emergency hospitalizations,
emergency room boarding, preventable emergency room visits, interaction
with the criminal justice system, homelessness, and unemployment; (B)
increased rates of employment and enrollment in educational and
vocational programs; (C) quality of mental and substance use disorders
treatment services; or (D) any other criteria determined by the
Secretary. Finally, the ISMICC will make specific recommendations for
actions that agencies can take to better coordinate the administration
of mental health services for adults with SMI or children with SED. Not
later than one (1) year after the date of enactment of the 21st Century
Cures Act, and five (5) years after such date of enactment, the ISMICC
shall submit a report to Congress and any other relevant federal
department or agency.
II. Membership
This ISMICC consists of federal members listed below or their
designees, and non-federal public members.
Federal Membership: Members include, The Secretary of Health and
Human Services; The Assistant Secretary for Mental Health and Substance
Use; The Attorney General; The Secretary of the Department of Veterans
Affairs; The Secretary of the Department of Defense; The Secretary of
the Department of Housing and Urban Development; The Secretary of the
Department of Education; The Secretary of the Department of Labor; The
Administrator of the Centers for Medicare and Medicaid Services; the
Administrator of the Administration for Community Living, and The
Commissioner of the Social Security Administration.
Non-Federal Membership: Members include, not less than 14 non-
federal public members appointed by the Secretary, representing
psychologists, psychiatrists, social workers, peer support specialists,
and other providers, patients, family of patients, law enforcement, the
judiciary, and leading research, advocacy, or service organizations.
The ISMICC is required to meet at least twice per year.
To attend virtually, submit written or brief oral comments, or
request special accommodation for persons with disabilities, contact
Pamela Foote. Individuals can also register at https://snacregister.samhsa.gov/.
The public comment section will be scheduled at the conclusion of
the meeting. Individuals interested in submitting a comment, must
notify Pamela Foote on or before March 18, 2024, via email to:
[email protected].
Up to three minutes will be allotted for each approved public
comment as time permits. Written comments received in advance of the
meeting will be considered for inclusion in the official record of the
meeting.
Substantive meeting information and a roster of Committee members
is available at the Committee's website: https://www.samhsa.gov/about-us/advisory-councils/ismicc.
Dated: February 12, 2024.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2024-03165 Filed 2-14-24; 8:45 am]
BILLING CODE 4162-20-P
